Major Differences
I. Royalty sharing
II. FLC
A. Funding level
B. Demonstration projects
C. Location
III. Appropriations
IV. Employee Activities
V. Agency plan
Other Differences
I. Organization
II. Senate amendments
A. Dole
B. Pell
C. Bumpers
D. Leahy
E. Domenici (remainder)
F. Gorton
III. Definition of Federal labs, cooperative research
IV. Reporting requirements
V. Professional mission statement
VI. Other
A. Technical Volunteer Program as example of FLC program (Senate)
B. "All" information should be transferred (House)
c. Regional/state/local FLC participation (Senate)
D. Licensing joint inventions (House)
E. Advance waivers (House)
F. Patent act conforming amendment
(second page, all handwritten)
OMB (Office of Management and Budget) reasons against:
(1). Royalty Sharing 
(2). Existence of Fed'l Lab. Consortium. 
(3). Renaming Agency.
Probably not objections at a high level.
House: DoD (Department of Defense) objection that hard to pick one invention. 
Patent law would control who investors are. 
Problem is most labs do not license anything so govt (government) loses.